A first-ever experiment shows how pigs might one day help people who have liver failure
Researchers at the University of Pennsylvania have externally attached a pig liver to a brain-dead human body and watched it successfully filter blood (Source: ABC News: Health)
Source: ABC News: Health - January 18, 2024 Category: Consumer Health News Tags: Health Source Type: news
How Pigs Could Help People Who Need Liver Transplants
In this study, eGenesis scientists used CRISPR to make not one, but 69 edits to the pig genome: three to remove the most pig-like proteins that would activate the human system to reject the liver, seven edits to add human genes to the pig liver, and 59 to inactivate pig retroviruses that could cause problems in humans. “Until CRISPR, there was no way to do that many edits easily,” says Curtis.
The future of pig livers
This single-patient study is just the beginning of what xenotransplants can achieve, says Shaked. The liver has two major duties in the body: regulating critical enzymes and substances such ...
Source: TIME: Health - January 18, 2024 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized healthscienceclimate Source Type: news
Subclasses of Steatotic Liver Disease Can Help Determine Prognosis
(MedPage Today) -- The new nomenclature for classifying steatotic liver disease (SLD) can help clinicians determine distinct prognoses, with the integration of alcohol intake as an aid in risk stratification, according to an analysis of a prospective... (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - January 18, 2024 Category: Psychiatry Source Type: news
How Independence Blue Cross boosted screenings for liver cancer by 110%
The Center City health insurer has adapted a platform developed at Penn Medicine to identify high-risk members. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - January 18, 2024 Category: Biotechnology Authors: John George Source Type: news
ACS: Cancer mortality declines, but incidence rates rise
Overall cancer mortality continues to decline, but incidence rates are up, according to a January 17 report by the American Cancer Society (ACS).
The report shows that there have been more than four million fewer deaths from cancer in the U.S. since 1991. However, it also showed increased incidence for six of the top 10 cancers as the projected number of new diagnoses is over two million for the first time.
“I think we’re all grappling with what the environmental factor that is changing the cancer incidence and mortality among the young," said ACS chief scientific officer William Dahut, MD, at a press conference.
AC...
Source: AuntMinnie.com Headlines - January 17, 2024 Category: Radiology Authors: Amerigo Allegretto Tags: Subspecialties CT Breast Imaging Source Type: news
Drug induced autoimmune hepatitis: an unfortunate case of herbal toxicity from Skullcap supplement: a case report - Thakral N, Konjeti VR, Salama FW.
BACKGROUND: The surge in traditional herbal dietary supplement (HDS) popularity has led to increased drug-induced liver injuries (DILI). Despite lacking evidence of efficacy and being prohibited from making medical claims, their acceptance has risen over s... (Source: SafetyLit)
Source: SafetyLit - January 17, 2024 Category: International Medicine & Public Health Tags: Home and Consumer Product Safety Source Type: news
The Hepatitis C Crisis Epitomizes The Problems With U.S. Healthcare
There has been a cure for Hepatitis C since 2014, yet nearly four million Americans are living with the viral infection, according to American Liver Foundation. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - January 16, 2024 Category: Pharmaceuticals Authors: Omer Awan, Contributor Tags: Healthcare /healthcare Innovation /innovation standard Source Type: news
What The Hepatitis C Crisis Says About The U.S. Healthcare System
There has been a cure for Hepatitis C since 2014, yet nearly 4 million Americans are living with the viral infection, according to American Liver Foundation. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - January 16, 2024 Category: Pharmaceuticals Authors: Omer Awan, Contributor Tags: Healthcare /healthcare Innovation /innovation standard Source Type: news
Patient adherence to ultrasound liver cancer surveillance recs is low
Patient adherence to ultrasound hepatocellular carcinoma (HCC) surveillance imaging recommendations has been suboptimal, according to research published January 12 in Radiology: Imaging Cancer.Ultrasound is considered a cost-effective surveillance method in the management of HCC, a common type of liver cancer associated with long-term liver damage and scarring of the liver and chronic infections such as hepatitis B and hepatitis C, a research team from the University of California, San Francisco (UCSF) noted. But whether patients comply with surveillance recommendations prompted by the ultrasound LI-RADS metric isn't cle...
Source: AuntMinnie.com Headlines - January 16, 2024 Category: Radiology Authors: AuntMinnie.com staff writers Tags: Industry News Source Type: news
European Commission approves Roche ’s Tecentriq SC, the EU's first PD-(L)1 cancer immunotherapy subcutaneous injection for multiple cancer types
Subcutaneous (SC) injection offers the potential for a faster, more convenient alternative to intravenous (IV) infusion and is preferred by cancer patients, nurses and physicians1-5Tecentriq SC reduces treatment time by approximately 80%, compared with standard IV infusion6Roche is working closely with national health systems in Europe to ensure patients can access Tecentriq SC as quickly as possibleBasel, 16 January 2024 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the European Commission has granted marketing authorisation for Tecentriq ® SC (atezolizumab), the European Union (EU)’s first PD-(L)1 cancer...
Source: Roche Investor Update - January 16, 2024 Category: Pharmaceuticals Source Type: news
European Commission approves Roche ’s Tecentriq SC, the EU's first PD-(L)1 cancer immunotherapy subcutaneous injection for multiple cancer types
Subcutaneous (SC) injection offers the potential for a faster, more convenient alternative to intravenous (IV) infusion and is preferred by cancer patients, nurses and physicians1-5Tecentriq SC reduces treatment time by approximately 80%, compared with standard IV infusion6Roche is working closely with national health systems in Europe to ensure patients can access Tecentriq SC as quickly as possibleBasel, 16 January 2024 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the European Commission has granted marketing authorisation for Tecentriq ® SC (atezolizumab), the European Union (EU)’s first PD-(L)1 cancer...
Source: Roche Media News - January 16, 2024 Category: Pharmaceuticals Source Type: news
Roy Calne, Pioneering British Organ-Transplant Surgeon, Dies at 93
His innovations in the use of drugs to prevent organ rejection helped bring a remarkable increase in the one-year survival rate. (Source: NYT Health)
Source: NYT Health - January 15, 2024 Category: Consumer Health News Authors: Clay Risen Tags: Roy Calne Deaths (Obituaries) Surgery and Surgeons Transplants Liver Doctors Great Britain Thomas Starzl Source Type: news
Dr Eric Berg shares two-ingredient drink for a fatty liver - 'one of my favourite drinks'
The ingredients in the drink have been found to have liver protecting effects, said Dr Eric Berg. (Source: Daily Express - Health)
Source: Daily Express - Health - January 15, 2024 Category: Consumer Health News Source Type: news
Reimbursement issues give impetus to AI adoption
Sanjay M. Parekh, PhD.The medical imaging AI market is forecast to reach almost $2 billion by 2027.1 It continues to evolve with sustained investment and a growing number of regulatory-cleared products. Nonetheless, adoption of AI solutions remains nascent and inconsistent. The market has yet to see widespread adoption of medical AI technologies, which requires widespread adoption for patient use (volumes), demand from referrers (awareness), and appropriate payment to providers (reimbursement).
The application of deep learning and convoluted neural networks to AI-powered technology solutions for medical imaging enables t...
Source: AuntMinnie.com Headlines - January 15, 2024 Category: Radiology Authors: Sanjay M. Parekh, PhD Tags: Artificial Intelligence Source Type: news
Research fuels advances in bile duct cancer care
Bile duct cancer, also known as cholangiocarcinoma, forms in the thin tubes that carry bile from your liver to your gallbladder and small intestine. Though relatively rare, cholangiocarcinoma is often diagnosed in later stages, making it more difficult to treat, and cases in the U.S. are increasing. In a review article published in Nature Reviews Clinical Oncology in 2023, lead author Sumera I. Ilyas, M.B.B.S., and co-authors share advances in diagnosing, staging and treating bile duct cancer. Dr.… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - January 13, 2024 Category: Databases & Libraries Source Type: news
